Pharma News

Simcere will make its appearance at ASCO in 2023 and will release a number of research data

2023-06-06: The American Society of Clinical Oncology (ASCO) 2023 Annual Meeting, one of the world's most influential oncology clinical academic events, was held in Chicago, USA on June 2-6 (Eastern Time) Simcere Pharmaceutical Group (2096.HK), an innovative biopharmaceutical company focused on the field of anti-tumor,  

 
NEWS.YAOZH 48 minutes ago 3 minutes read

 
Hengrui Medicine's "Shuangai" Combination Treatment for Endometrial Cancer Research Presents Oral Report

2023-06-06: At the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO), Professor Tian Wenbin of Fudan University Hospital of Cancer presented the latest results of the Phase I clinical study of patients with advanced or recurrent endometrial cancer treated with Erika and Aetan ("double moxibustion"  

 
NEWS.YAOZH 48 minutes ago 3 minutes read

 
The legendary biological Cedar Giorenza can reduce the risk of disease progression or death by 74 percent

2023-06-06: On June 5, 2023, Legendary Creatures announced data from the third phase of its CARTITUDE-4 study in Somerset, New Jersey. The results showed that at the median follow-up of 16 months, Sidakiolamide reduced the risk of disease progression or death by 74 percent (risk ratios of 0.26, 95 percent CI, 0.18-0.38,  

 
NEWS.YAOZH 48 minutes ago 4 minutes read

 
Working Video Display of Oral Liquid Filling and Capping Machine Production Line-Online Video-Pharmaceutical Network


ZYZHAN 48 minutes ago 1 minute read

 
Junshi Biotech plans to issue GDR overseas; Kelun Botai passed the hearing of the Hong Kong Stock Exchange

2023-06-06: https: www.cphi.cn. 2023-06-06. 09: 32. Source: Amino Observation. Author: Linzhuo Xu On June 5, Junshi Biotech announced that it intends to issue additional domestic basic shares of GDR overseas. The funds raised for this issue will be USD, and the total amount raised will not exceed RMB 3.4 billion  

 
CPHI 50 minutes ago 2 minutes read

 
Yesterday, the traditional Chinese medicine sector strengthened, and Jiuzhitang and others closed the daily limit


ZYZHAN 48 minutes ago 1 minute read

 
How to delay the progress of myopia in children? Detailed explanation by ophthalmologists

2023-06-06: Child myopia has become a heart disease for many parents. According to the survey, the overall myopia rate among children and adolescents is 53.6 per cent Zheng Xiaoyu, deputy director of ophthalmology at the Children's Hospital Affiliated to Zhejiang University School of Medicine, said that for children  

 
CE 40 minutes ago 1 minute read

 
Just! Novartis' blockbuster rare disease innovative drug to be included in priority review

2023-06-06: Today (June 5), the official website of the Drug Evaluation Center (CDE) of the State Food and Drug Administration of China showed that the Epricotide hydrochloride capsules applied by Beijing Novartis Pharmaceutical Co., Ltd. Source: CDE official website The project code name for iptacopan  

 
NEWS.YAOZH 48 minutes ago 1 minute read

 
Cultivation of a medicine king: no chance, no fluke

2023-06-06: https: www.cphi.cn. 2023-06-06. 09: 15. Source: Amino Observations. Author: Huang Qi Since its birth, K medicine has been running for many years and has been firmly occupying the world's No.1 throne. For now, it still sees no signs of slowing down. In the first quarter of 2023, global sales of K  

 
CPHI 50 minutes ago 2 minutes read

 
The trend of Hong Kong pharmaceutical stocks diverges, Kintor Pharmaceuticals fell by more than 3 percent

2023-06-06: How expensive is it to make your own foundation and skin care products?  

 
JIEMIAN 45 minutes ago 1 minute read

 
Jiangsu's Anti-corruption Increased. Bribery and bribery investigation together-News-tianya pharmaceutical network

2023-06-06: Jiangsu Anti-corruption Plus released a strong signal of "paying bribes and accepting bribes together." Bribery pattern renovation, focus on crackdown Recently, the Supervisory Commission of Jiangsu Provincial Commission for Discipline Inspection formulated and issued "Opinions on Strengthening the  

 
WUHANTY 50 minutes ago 1 minute read

 
Betta Pharmaceuticals BPI-16350 confirms ORR as high as 60.5 percent

2023-06-06: On June 2-6, the 59th annual meeting of the American Society of Clinical Oncology (ASCO) was held in Chicago. Data from the Phase I clinical study conducted by Betta Pharmaceuticals BPI-16350 in patients with HR / HER2 - advanced metastatic breast cancer were presented in summary form, confirming an  

 
NEWS.YAOZH 48 minutes ago 2 minutes read

 
In the first five months of 2023, 34 children's medicines were approved for marketing. The number exceeded the same period last year

2023-06-06: From January to May 2023, 34 pediatric drugs have been approved for sale, more than in the same period last year, covering areas such as rare diseases in children, common diseases in children with multiple diseases, and critical children. This is what journalists learned from the 2023 Symposium on Promoting  

 
NEWS.YAOZH 48 minutes ago 1 minute read

 
The key to restricting the prospect of GLP-1 is not the indication but the production capacity

2023-06-06: https: www.cphi.cn. 2023-06-06. 09: 26. Source: Amino Observation. Author: Linzhuo Xu In most cases, the central factor limiting drug prospects is the indication. The approval of a large indication means the drug's prospects are expected to improve significantly. But there are always exceptions,  

 
CPHI 50 minutes ago 1 minute read

 
21 Jianxun Daily|7 pharmaceutical companies have encountered anti-monopoly administrative penalties; the FDA has specially approved the rapid launch of Chinese anticancer drugs for emergency

2023-06-06: Health news early to know, heavy news read! New health, new trends, all at 21 Health News Daily! Here is "21JianXun Daily," welcome to follow the latest events in the pharmaceutical and health industry with 21st Century Economic Report New Health Team! I. Policy developments 7 pharmaceutical companies

 
21JINGJI 54 minutes ago 4 minutes read

 
Guosen Securities: The cost performance of growth assets is prominent. Actively allocate innovative pharmaceutical and device companies

2023-06-06: Source: Securities Times e Inc. Editor-in-Charge: 6 Original title: Guoxin Securities: growth assets cost-effective highlights. Actively allocate innovative pharmaceutical enterprises Operate accordingly at your own risk.  

 
FINANCE.EASTMONEY 55 minutes ago 1 minute read

 
For the first time, a Chinese pharmaceutical company supplies drugs in short supply to the United States with products sold in the domestic market

2023-06-06: Titanium Media App. On June 6 news, the U.S. Food and Drug Administration (FDA) is easing regulations on importing certain chemotherapy drugs to address the shortage of anti-cancer drugs. The agency said it would allow Chinese drugmaker Qilu Pharmaceuticals to ship a chemotherapy injection called cisplatin  

 
TMTPOST 1 hour ago 1 minute read

 
Fund net value on June 5: The latest net value of E Fund CSI 300 Pharmaceutical ETF is 0.44, down 0.61 percent


SOHU 1 hour ago 1 minute read

 
Chinese pharmaceutical companies have received an urgent email from the FDA. There is a severe shortage in the United States, and they are asking whether they can supply...


IFENG 1 hour ago 1 minute read

 
Innovative Service Station Helps Pharmaceutical Companies "Hurry Up"

2023-06-06: Promote service station model, provide timely information services for enterprises; practical recruitment of difficulties encountered by enterprises. Beijing Food and Drug Administration takes the needs of the masses as its starting point and starting point, and strives to open up the "last mile" to  

 
BJD 2 hours ago 1 minute read

 

Load More



Trending in China

What China Reads


Pharma News


Simcere will make its appearance at ASCO in 2023 and will release a number of research data

2023-06-06: The American Society of Clinical Oncology (ASCO) 2023 Annual Meeting, one of the world's most influential oncology clinical academic events, was held in Chicago, USA on June 2-6 (Eastern Time) Simcere Pharmaceutical Group (2096.HK), an innovative biopharmaceutical company focused on the field of anti-tumor,  


NEWS.YAOZH 48 minutes ago 3 minutes read

 

Hengrui Medicine's "Shuangai" Combination Treatment for Endometrial Cancer Research Presents Oral Report

2023-06-06: At the 2023 Annual Meeting of the American Society of Clinical Oncology (ASCO), Professor Tian Wenbin of Fudan University Hospital of Cancer presented the latest results of the Phase I clinical study of patients with advanced or recurrent endometrial cancer treated with Erika and Aetan ("double moxibustion"  


NEWS.YAOZH 48 minutes ago 3 minutes read

 

The legendary biological Cedar Giorenza can reduce the risk of disease progression or death by 74 percent

2023-06-06: On June 5, 2023, Legendary Creatures announced data from the third phase of its CARTITUDE-4 study in Somerset, New Jersey. The results showed that at the median follow-up of 16 months, Sidakiolamide reduced the risk of disease progression or death by 74 percent (risk ratios of 0.26, 95 percent CI, 0.18-0.38,  


NEWS.YAOZH 48 minutes ago 4 minutes read

 
Working Video Display of Oral Liquid Filling and Capping Machine Production Line-Online Video-Pharmaceutical Network


ZYZHAN 48 minutes ago 1 minute read

 

Junshi Biotech plans to issue GDR overseas; Kelun Botai passed the hearing of the Hong Kong Stock Exchange

2023-06-06: https: www.cphi.cn. 2023-06-06. 09: 32. Source: Amino Observation. Author: Linzhuo Xu On June 5, Junshi Biotech announced that it intends to issue additional domestic basic shares of GDR overseas. The funds raised for this issue will be USD, and the total amount raised will not exceed RMB 3.4 billion  


CPHI 50 minutes ago 2 minutes read

 
Yesterday, the traditional Chinese medicine sector strengthened, and Jiuzhitang and others closed the daily limit


ZYZHAN 48 minutes ago 1 minute read

 

How to delay the progress of myopia in children? Detailed explanation by ophthalmologists

2023-06-06: Child myopia has become a heart disease for many parents. According to the survey, the overall myopia rate among children and adolescents is 53.6 per cent Zheng Xiaoyu, deputy director of ophthalmology at the Children's Hospital Affiliated to Zhejiang University School of Medicine, said that for children  


CE 40 minutes ago 1 minute read

 

Just! Novartis' blockbuster rare disease innovative drug to be included in priority review

2023-06-06: Today (June 5), the official website of the Drug Evaluation Center (CDE) of the State Food and Drug Administration of China showed that the Epricotide hydrochloride capsules applied by Beijing Novartis Pharmaceutical Co., Ltd. Source: CDE official website The project code name for iptacopan  


NEWS.YAOZH 48 minutes ago 1 minute read

 

Cultivation of a medicine king: no chance, no fluke

2023-06-06: https: www.cphi.cn. 2023-06-06. 09: 15. Source: Amino Observations. Author: Huang Qi Since its birth, K medicine has been running for many years and has been firmly occupying the world's No.1 throne. For now, it still sees no signs of slowing down. In the first quarter of 2023, global sales of K  


CPHI 50 minutes ago 2 minutes read

 

The trend of Hong Kong pharmaceutical stocks diverges, Kintor Pharmaceuticals fell by more than 3 percent

2023-06-06: How expensive is it to make your own foundation and skin care products?  


JIEMIAN 45 minutes ago 1 minute read

 

Jiangsu's Anti-corruption Increased. Bribery and bribery investigation together-News-tianya pharmaceutical network

2023-06-06: Jiangsu Anti-corruption Plus released a strong signal of "paying bribes and accepting bribes together." Bribery pattern renovation, focus on crackdown Recently, the Supervisory Commission of Jiangsu Provincial Commission for Discipline Inspection formulated and issued "Opinions on Strengthening the  


WUHANTY 50 minutes ago 1 minute read

 

Betta Pharmaceuticals BPI-16350 confirms ORR as high as 60.5 percent

2023-06-06: On June 2-6, the 59th annual meeting of the American Society of Clinical Oncology (ASCO) was held in Chicago. Data from the Phase I clinical study conducted by Betta Pharmaceuticals BPI-16350 in patients with HR / HER2 - advanced metastatic breast cancer were presented in summary form, confirming an  


NEWS.YAOZH 48 minutes ago 2 minutes read

 

In the first five months of 2023, 34 children's medicines were approved for marketing. The number exceeded the same period last year

2023-06-06: From January to May 2023, 34 pediatric drugs have been approved for sale, more than in the same period last year, covering areas such as rare diseases in children, common diseases in children with multiple diseases, and critical children. This is what journalists learned from the 2023 Symposium on Promoting  


NEWS.YAOZH 48 minutes ago 1 minute read

 

The key to restricting the prospect of GLP-1 is not the indication but the production capacity

2023-06-06: https: www.cphi.cn. 2023-06-06. 09: 26. Source: Amino Observation. Author: Linzhuo Xu In most cases, the central factor limiting drug prospects is the indication. The approval of a large indication means the drug's prospects are expected to improve significantly. But there are always exceptions,  


CPHI 50 minutes ago 1 minute read

 

21 Jianxun Daily|7 pharmaceutical companies have encountered anti-monopoly administrative penalties; the FDA has specially approved the rapid launch of Chinese anticancer drugs for emergency

2023-06-06: Health news early to know, heavy news read! New health, new trends, all at 21 Health News Daily! Here is "21JianXun Daily," welcome to follow the latest events in the pharmaceutical and health industry with 21st Century Economic Report New Health Team! I. Policy developments 7 pharmaceutical companies


21JINGJI 54 minutes ago 4 minutes read

 

Guosen Securities: The cost performance of growth assets is prominent. Actively allocate innovative pharmaceutical and device companies

2023-06-06: Source: Securities Times e Inc. Editor-in-Charge: 6 Original title: Guoxin Securities: growth assets cost-effective highlights. Actively allocate innovative pharmaceutical enterprises Operate accordingly at your own risk.  


FINANCE.EASTMONEY 55 minutes ago 1 minute read

 

For the first time, a Chinese pharmaceutical company supplies drugs in short supply to the United States with products sold in the domestic market

2023-06-06: Titanium Media App. On June 6 news, the U.S. Food and Drug Administration (FDA) is easing regulations on importing certain chemotherapy drugs to address the shortage of anti-cancer drugs. The agency said it would allow Chinese drugmaker Qilu Pharmaceuticals to ship a chemotherapy injection called cisplatin  


TMTPOST 1 hour ago 1 minute read

 
Fund net value on June 5: The latest net value of E Fund CSI 300 Pharmaceutical ETF is 0.44, down 0.61 percent


SOHU 1 hour ago 1 minute read

 
Chinese pharmaceutical companies have received an urgent email from the FDA. There is a severe shortage in the United States, and they are asking whether they can supply...


IFENG 1 hour ago 1 minute read

 

Innovative Service Station Helps Pharmaceutical Companies "Hurry Up"

2023-06-06: Promote service station model, provide timely information services for enterprises; practical recruitment of difficulties encountered by enterprises. Beijing Food and Drug Administration takes the needs of the masses as its starting point and starting point, and strives to open up the "last mile" to  


BJD 2 hours ago 1 minute read

 

Load More